These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 22649045

  • 1. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J, Wan S, Tian J, Li S, Deng D, Qian Z, Gu Y.
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [Abstract] [Full Text] [Related]

  • 2. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.
    Wu Y, Cai W, Chen X.
    Mol Imaging Biol; 2006; 8(4):226-36. PubMed ID: 16791749
    [Abstract] [Full Text] [Related]

  • 3. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z, Wu Y, Xiong Z, Gambhir SS, Chen X.
    Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
    [Abstract] [Full Text] [Related]

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
    Ye Y, Bloch S, Xu B, Achilefu S.
    J Med Chem; 2006 Apr 06; 49(7):2268-75. PubMed ID: 16570923
    [Abstract] [Full Text] [Related]

  • 6. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X.
    J Nucl Med; 2007 Jul 06; 48(7):1162-71. PubMed ID: 17574975
    [Abstract] [Full Text] [Related]

  • 7. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
    Hsu AR, Hou LC, Veeravagu A, Greve JM, Vogel H, Tse V, Chen X.
    Mol Imaging Biol; 2006 Jul 06; 8(6):315-23. PubMed ID: 17053862
    [Abstract] [Full Text] [Related]

  • 8. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
    Chen X, Conti PS, Moats RA.
    Cancer Res; 2004 Nov 01; 64(21):8009-14. PubMed ID: 15520209
    [Abstract] [Full Text] [Related]

  • 9. RGD-human serum albumin conjugates as efficient tumor targeting probes.
    Chen K, Xie J, Chen X.
    Mol Imaging; 2009 Nov 01; 8(2):65-73. PubMed ID: 19397852
    [Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
    Zhang X, Chen X.
    Appl Radiat Isot; 2007 Jan 01; 65(1):70-8. PubMed ID: 17011200
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S, Miao Z, Liu H, Xu Y, Feng Y, Cheng Z.
    Bioconjug Chem; 2012 Jun 20; 23(6):1149-56. PubMed ID: 22621238
    [Abstract] [Full Text] [Related]

  • 12.
    Cheng KT.
    ; 2004 Jun 20. PubMed ID: 20641381
    [Abstract] [Full Text] [Related]

  • 13. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
    Cai W, Chen K, Li ZB, Gambhir SS, Chen X.
    J Nucl Med; 2007 Nov 20; 48(11):1862-70. PubMed ID: 17942800
    [Abstract] [Full Text] [Related]

  • 14.
    Cheng KT, Razkin J, Josserand V, Jin Z, Foillard S, Boturyn D, Favrot PMC, Dumy P, Coll JL.
    ; 2004 Nov 20. PubMed ID: 20641805
    [Abstract] [Full Text] [Related]

  • 15. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
    Zheng X, Xing D, Zhou F, Wu B, Chen WR.
    Mol Pharm; 2011 Apr 04; 8(2):447-56. PubMed ID: 21197955
    [Abstract] [Full Text] [Related]

  • 16. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
    Mathejczyk JE, Pauli J, Dullin C, Napp J, Tietze LF, Kessler H, Resch-Genger U, Alves F.
    Mol Imaging; 2011 Dec 04; 10(6):469-80. PubMed ID: 22201538
    [Abstract] [Full Text] [Related]

  • 17. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.
    Edwards WB, Akers WJ, Ye Y, Cheney PP, Bloch S, Xu B, Laforest R, Achilefu S.
    Mol Imaging; 2009 Dec 04; 8(2):101-10. PubMed ID: 19397855
    [Abstract] [Full Text] [Related]

  • 18. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z, Jia B, Shi J, Jin X, Zhao H, Li F, Liu S, Wang F.
    Bioconjug Chem; 2010 Mar 17; 21(3):548-55. PubMed ID: 20184307
    [Abstract] [Full Text] [Related]

  • 19. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
    Liu Z, Liu S, Niu G, Wang F, Liu S, Chen X.
    Mol Imaging; 2010 Feb 17; 9(1):21-9. PubMed ID: 20128995
    [Abstract] [Full Text] [Related]

  • 20. Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo.
    Guo J, Du C, Shan L, Zhu H, Xue B, Qian Z, Achilefu S, Gu Y.
    Contrast Media Mol Imaging; 2012 Feb 17; 7(3):289-301. PubMed ID: 22539399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.